Evidence map›Paper›PMID 39967043›Full record

ArticleClinical and experimental dental research2025

Cytotoxicity of Different Concentrations of Silver Nanoparticles and Calcium Hydroxide for MC3T3-E1 Preosteoblast Cell Line.

Farzaneh Afhkami, Paniz Ahmadi, Golriz Rostami

Abstract read
In one paragraph

Article in Clinical and experimental dental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Farzaneh AfhkamiTehran University of Medical Sciences, Tehran, Iran.
Paniz AhmadiPrivate practice, Tehran, Iran.
Golriz RostamiPrivate practice, Toronto, Canada.ORCID 0000-0002-2576-5902

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

introductionWith the advances in nanotechnology, nanomaterials are increasingly used in various fields due to their antibacterial properties; therefore, assessing the benefits and risks associated with the application of medicaments is imperative. This study evaluated the cytotoxicity of different concentrations of silver nanoparticles (AgNPs) and calcium hydroxide (CH) for MC3T3-E1 preosteoblast cell line. MATERIAL AND

methodsThe MC3T3-E1 preosteoblast cells were exposed to triple antibiotic paste (TAP), AgNPs, CH, and different concentrations of AgNPs mixed with CH in 1:1, 1:2, and 1:3 ratios for 24, 48, and 72 h. Cytotoxicity was evaluated by the methyl thiazolyl tetrazolium (MTT) assay, and also the colony formation assay (CFA) was performed.

resultsAt 24 h, the TAP and AgNPs groups showed the highest and the CH-AgNPs/1:3 group had the lowest cell viability percentage in comparison to the other experimental groups. At 48 h, the TAP group showed the highest and the CH-AgNPs/1:3 group showed the lowest cell viability. At 72 h, the AgNPs and CH groups showed the highest viability, while the lowest viability was noted in the CH-AgNPs/1:3 and CH-AgNPs/1:2 groups.

conclusionAgNPs showed the least cytotoxic effects in all periods. The addition of AgNPs to CH increases the cytotoxic effects of CH on experimental cells. After 48 and 72 h, CH-AgNPs/1:1 showed significantly higher cell viability in comparison to higher concentrations.

Indexed as

Calcium HydroxideMetal NanoparticlesOsteoblastsSilverAnimalsAnti-Bacterial AgentsCell LineCell SurvivalDose-Response Relationship, DrugMiceAnti-Bacterial AgentsCalcium HydroxideSilvercalcium hydroxidecytotoxicity testsdental disinfectantssilver nanoparticlestriple antibiotic Paste

Identifiers

PMID39967043
PMCPMC11835769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.